Latest Debt Repayment News

Anteris Technologies Global Corp. reported a $21.9 million net loss for Q1 2025, driven by increased R&D spending as it scales manufacturing and prepares pivotal trials for its DurAVR Transcatheter Heart Valve. The company’s recent $80 million IPO proceeds are being deployed to support these efforts and repay debt.

Envirosuite Limited has entered a binding Scheme Implementation Deed with UK-based Ideagen Limited, agreeing to a full acquisition at a significant premium. The transaction values Envirosuite at approximately A$132.2 million and awaits shareholder and regulatory approvals.

Althea Group Holdings has agreed to sell its pharmaceutical assets to Tasmanian Botanics, enabling a strategic pivot towards the booming North American THC-infused beverage market.

DTI Group Limited has announced a fully underwritten pro-rata entitlement offer to raise approximately $2.69 million, primarily aimed at repaying a $1.25 million loan from major shareholder Finico Pty Ltd. The offer opens on 13 May and closes on 10 June 2025, with new shares priced at $0.006 each.

Saferoads Holdings has finalised the sale of its Road Safety Rentals assets, repaid all related debts, and announced a fully franked 10 cent special dividend for shareholders.

Mighty Kingdom Limited reports a positive operating cash inflow and significant cost reductions in Q3 FY25, alongside leadership changes and a $3.35 million capital raise underway to fuel growth.

High Peak Royalties reported steady royalty income for Q1 2025, completed a significant geothermal asset sale to Northstar Energy, and achieved a debt-free balance sheet following full repayment of its Macquarie facility.

TZ Limited reported a challenging Q3 FY2025 with a $1.03 million net cash outflow amid US tariff disruptions but strengthened its SaaS base through the Keyvision acquisition, positioning for a rebound and growth in FY2026.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Propell Holdings reports Q3 FY25 cash outflows alongside a strategic shift with a new ‘Low Doc’ credit model and confirms its upcoming ASX delisting.

Saferoads Holdings reports a modest quarterly profit driven by cost cuts and prepares to settle the sale of its Road Safety Rentals business, aiming to clear debt and refocus on product sales growth.

ADX Energy Ltd reported a solid cash balance of A$6.67 million at the end of Q1 2025, despite significant investment in exploration activities and ongoing loan repayments. The company’s quarterly cash flow highlights its commitment to advancing projects while managing financial stability.